Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 by Intellectual Property Watch Leave a Comment Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance.
“We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week’s Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed.
FIND Announces Four New Collaborations To Address AMR 31/01/2018 by Intellectual Property Watch Leave a Comment The Foundation for Innovative New Diagnostics (FIND) yesterday announced the release of a new strategy on antimicrobial resistance (AMR).
The Top 5 Issues In EU Medicines Policy For 2018 (Including IP) 30/01/2018 by Intellectual Property Watch 1 Comment Yannis Natsis writes: There is a breakdown in communications between the pharmaceutical industry and Ministers of Health in Europe. The newly-deployed tactic of public, personalised attacks on national decision-makers who express concerns over high prices of medicines, reveal a change in the industry’s lobbying strategy that might damage the relationship irreparably.
WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval 29/01/2018 by Catherine Saez, Intellectual Property Watch 5 Comments The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments.
WHO Antibiotic Resistance Data Shows Worrying Trend; Industry Ready To Help 29/01/2018 by Catherine Saez, Intellectual Property Watch 2 Comments Today the World Health Organization released its first set of surveillance data on antibiotic resistance. The data shows that resistance to antibiotics is growing among the world’s most common bacteria, in both high- and low-income countries. Industry announced that it is in the process of making its surveillance data available.
WHO Executive Board Agrees On Actions To Boost R&D, Access To Medicines 26/01/2018 by Catherine Saez, Intellectual Property Watch 3 Comments After long deliberations, the World Health Organization Executive Board agreed this morning to ask member states and the organisation to implement recommendations aiming at improving innovation and access to medicines. Three recommendations, specifically aimed at member states, including on the transparency on the cost of research and development of medicines, met resistance by some countries and were left hanging, to be discussed by member states with no timeframe.
New Text Shows Progress Of Negotiation On IP And Access At WHO 25/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment The Brazilian ambassador and others this morning at the World Health Organization Executive Board meeting were not going to let go of what seemed to be a delaying tactic by the United States and Japan to postpone agreement on the implementation of measures aimed at facilitating research and development and access to medicines. The WHO Board today is considering a set of streamlined strategic measures on public health, innovation, and intellectual property.
Panel Spells Out Key Intellectual Property Issues For Venture Capitalists 24/01/2018 by Dugie Standeford for Intellectual Property Watch Leave a Comment Intellectual property issues are becoming increasingly important to venture capital investment decisions, speakers said at a recent American Bar Association webinar.
Antimicrobial Benchmark For Industry Launched In Davos 23/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment Across the Alps from this week’s World Health Organization Executive Board meeting, the first ever antimicrobial resistance benchmark was launched today at the World Economic Forum annual meeting in Davos.